Does cholesterol medicine cause joint pain
Pro Research Analysisby 
Searched over 200M research papers
Cholesterol Medication and Joint Pain: An Analysis
Introduction to Cholesterol Medication and Joint Pain
Cholesterol medications, particularly statins, are widely prescribed to manage high cholesterol levels and reduce the risk of cardiovascular diseases. However, there have been concerns about potential side effects, including joint pain. This article synthesizes research findings to explore whether cholesterol medications cause joint pain.
Hypercholesterolemia and Joint Pain
Hypercholesterolemia itself has been linked to joint pain. A study on primary biliary cirrhosis patients found that high cholesterol levels could provoke acute inflammatory periarthritis and peritendinitis, leading to sudden onset of peripheral joint pain and effusion 2. This suggests that elevated cholesterol levels might contribute to joint pain independently of medication.
Cholesterol Depletion and Pain Transmission
Research has shown that cholesterol plays a crucial role in neuronal pathophysiology. A study revealed that inflammation lowers cholesterol content in skin tissue and sensory neurons, which sensitizes nociceptive neurons and promotes hyperalgesia through the activation of Nav1.9 channels 6. This indicates that changes in cholesterol levels, whether due to disease or medication, can influence pain perception.
Glucosamine and Cholesterol Levels
Interestingly, a clinical study investigated whether glucosamine sulfate, a supplement often used for joint pain, affects cholesterol levels. The study found no significant differences in cholesterol and triglyceride levels between the glucosamine group and the placebo group, suggesting that glucosamine does not influence cholesterol metabolism 5. This is relevant as it highlights that not all substances affecting joints have an impact on cholesterol levels.
Conclusion
The relationship between cholesterol medication and joint pain is complex. While hypercholesterolemia itself can cause joint pain, the role of cholesterol medications in exacerbating or alleviating this pain is less clear. Changes in cholesterol levels can affect pain transmission, but more research is needed to fully understand the mechanisms and implications. Patients experiencing joint pain while on cholesterol medication should consult their healthcare provider to explore potential causes and treatment options.
Sources and full results
Most relevant research papers on this topic
Targeting Soluble Epoxide Hydrolase and Cyclooxygenases Enhance Joint Pain Control, Stimulate Collagen Synthesis, and Protect Chondrocytes From Cytokine-Induced Apoptosis
Combined COX and sEH inhibition improve joint pain control, stimulate collagen synthesis, and protect chondrocytes from cytokine-induced apoptosis during joint inflammation.
RCT
Animal StudyHypercholesterolaemic arthropathy in primary biliary cirrhosis.
Hypercholesterolaemia can cause acute inflammatory periarthritis and peritendinitis in primary biliary cirrhosis patients, with Cholestyramine potentially helping to prevent this form of arthritis.
Case ReportChondroitin for osteoarthritis.
Chondroitin may provide a small improvement in pain levels for osteoarthritis patients compared to placebo, but its effectiveness remains unclear and its long-term safety remains unclear.
Meta-Analysis
Very Rigorous Journal
Highly CitedChondroitin sulfate from sturgeon bone ameliorates pain of osteoarthritis induced by monosodium iodoacetate in rats.
Chondroitin sulfate from sturgeon bone effectively reduces osteoarthritis pain induced by monosodium iodoacetate in rats, making it a potential medicinal ingredient.
Non-RCTAnimal Study[The effect of glucosamine sulphate on the blood levels of cholesterol or triglycerides--a clinical study].
Glucosamine sulphate does not significantly influence blood levels of cholesterol or triglycerides in patients with chronic joint pain.
RCTMembrane cholesterol depletion as a trigger of Nav1.9 channel‐mediated inflammatory pain
Membrane cholesterol plays a crucial role in controlling pain transmission, with inflammation lowering cholesterol levels and promoting hyperalgesia through voltage-gated Nav1.9 channels.
In Vitro StudyA meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain
Omega-3 PUFA supplementation for 3-4 months reduces patient reported joint pain intensity, morning stiffness, and NSAID consumption in patients with rheumatoid arthritis, inflammatory bowel disease, and dysmenorrhea.
Meta-AnalysisHighly CitedOsteoarthritis development is induced by increased dietary cholesterol and can be inhibited by atorvastatin in APOE*3Leiden.CETP mice—a translational model for atherosclerosis
Increased dietary cholesterol contributes to osteoarthritis development, and atorvastatin effectively suppresses it in mice, while ezetimibe shows no significant effect.
Highly CitedThe endogenous adjuvant squalene can induce a chronic T-cell-mediated arthritis in rats.
Squalene injections can trigger chronic, immune-mediated joint-specific inflammation in arthritis-prone rats, potentially offering clues to the pathogenesis of rheumatoid arthritis.
Non-RCTAnimal StudyHighly CitedDietary Supplements of Shiikuwasha Extract Attenuates Osteoarthritis Progression in Meniscal/ligamentous Injury and Obese Rats
Shiikuwasha extract can reduce osteoarthritis progression and improve obesity by reducing weight gain and joint pain in rats.
Non-RCTAnimal StudyVery Rigorous Journal